Publications by authors named "A M Billi"

Objective: Cutaneous lupus erythematosus (CLE) is an inflammatory skin manifestation of systemic lupus erythematosus (SLE). Type I interferons (IFNs) promote inflammatory responses and are elevated in CLE lesions. We recently reported that CLE lesions are frequently colonized with Staphylococcus aureus (S.

View Article and Find Full Text PDF

Background: Cutaneous lichen planus (LP) is a recalcitrant, difficult-to-treat, inflammatory skin disease characterized by pruritic, flat-topped, violaceous papules on the skin. Baricitinib is an oral Janus kinase (JAK) 1/2 inhibitor that interrupts the signaling pathway of interferon gamma (IFN)-γ, a cytokine implicated in the pathogenesis of LP.

Methods: In this phase II trial, twelve patients with cutaneous LP received baricitinib 2 mg daily for 16 weeks, accompanied by in-depth spatial, single-cell, and bulk transcriptomic profiling of pre- and post-treatment samples.

View Article and Find Full Text PDF

The two Mw > 7.5 earthquakes that struck the East Anatolian Fault (EAF), Türkiye, in 2023 caused more slip than expected, indicating that they were potentially part of a supercycle, in which the occurrence probability of a large earthquake is determined by accumulated strain rather than time since the last large earthquake. Here, we show two potential supercycles along the EAF, analyzing earthquakes from the last two millennia.

View Article and Find Full Text PDF

The expressions of long noncoding RNAs (lncRNAs) and their roles in epidermal differentiation have been previously defined using bulk RNA sequencing. Despite their tissue-specific expression profiles, most lncRNAs are not well-annotated at the single-cell level. In this study, we evaluated the use of single-cell RNA sequencing to profile and characterize lncRNAs using data from 6 patients with psoriasis with paired uninvolved and lesional psoriatic skin.

View Article and Find Full Text PDF
Article Synopsis
  • - Sweet's syndrome is an inflammatory skin disease involving the influx of neutrophils in the skin, and it features a strong interferon response that's not seen in other similar skin conditions.
  • - Research using advanced techniques on skin samples found that various cells, especially fibroblasts, display genes activated by interferons, suggesting they respond to inflammation.
  • - The study highlights specific fibroblast populations in Sweet's syndrome that are located at different distances from neutrophils, indicating their potential role in the disease's development by responding to type I interferons.
View Article and Find Full Text PDF